Biolinerx Stock Price on December 10, 2024
| BLRX Stock | USD 0.22 0.01 4.35% |
Below is the normalized historical share price chart for BioLineRx extending back to July 25, 2011. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of BioLineRx stands at 0.22, as last reported on the 27th of December, with the highest price reaching 0.26 and the lowest price hitting 0.22 during the day.
If you're considering investing in BioLineRx Stock, it is important to understand the factors that can impact its price. BioLineRx secures Sharpe Ratio (or Efficiency) of -0.16, which signifies that the company had a -0.16% return per unit of risk over the last 3 months. BioLineRx exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BioLineRx's Risk Adjusted Performance of (0.14), mean deviation of 4.28, and Standard Deviation of 7.04 to double-check the risk estimate we provide.
At this time, BioLineRx's Common Stock Shares Outstanding is fairly stable compared to the past year. Common Stock is likely to rise to about 32.9 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 12.6 M in 2024. . At this time, BioLineRx's Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 8.27 in 2024, whereas Price To Sales Ratio is likely to drop 10.09 in 2024. BioLineRx Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of July 2011 | 200 Day MA 0.6216 | 50 Day MA 0.3578 | Beta 0.873 |
BioLineRx |
Sharpe Ratio = -0.1598
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BLRX |
Estimated Market Risk
| 7.11 actual daily | 63 63% of assets are less volatile |
Expected Return
| -1.14 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average BioLineRx is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioLineRx by adding BioLineRx to a well-diversified portfolio.
Price Book 2.3083 | Enterprise Value Ebitda (0.67) | Price Sales 1.3585 | Shares Float 1.1 B | Wall Street Target Price 4.5667 |
BioLineRx Main Headline on 10th of December 2024
Silexion Therapeutics Appoints Renowned Cancer Therapeutics ... by finance.yahoo.com
Prof. Peled, a globally recognized scientific authority who has been involved in multiple successful publicly traded bio-pharma companies, will assist Silexion as it advances its RNAi platform and next-generation therapies targeting KRAS mutationsCayman Islands, December 10, 2024 Silexion Therapeutics Corp. , a clinical-stage biotech developing RNA interference therapies for KRAS-driven cancers, today announced the appointment of Prof. Amnon P
BioLineRx Valuation on December 10, 2024
It is possible to determine the worth of BioLineRx on a given historical date. On December 10, 2024 BioLineRx was worth 0.26 at the beginning of the trading date compared to the closed value of 0.24. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of BioLineRx stock. Still, in general, we apply an absolute valuation method to find BioLineRx's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of BioLineRx where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against BioLineRx's related companies.
| Open | High | Low | Close | Volume | |
| 0.26 | 0.27 | 0.24 | 0.25 | 1,379,154 | |
12/10/2024 | 0.26 | 0.26 | 0.23 | 0.24 | 1,370,404 |
| 0.24 | 0.25 | 0.22 | 0.24 | 1,525,404 |
| Backtest BioLineRx | | | BioLineRx History | | | BioLineRx Valuation | Previous | Next |
BioLineRx Trading Date Momentum on December 10, 2024
| On December 11 2024 BioLineRx was traded for 0.24 at the closing time. The top price for the day was 0.25 and the lowest listed price was 0.22 . The trading volume for the day was 1.5 M. The trading history from December 11, 2024 did not affect price variability. The overall trading delta against the current closing price is 12.50% . |
BioLineRx Fundamentals Correlations and Trends
By evaluating BioLineRx's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among BioLineRx's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. BioLineRx financial account trend analysis is a perfect complement when working with valuation or volatility modules.About BioLineRx Stock history
BioLineRx investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BioLineRx is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BioLineRx will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BioLineRx stock prices may prove useful in developing a viable investing in BioLineRx
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 64.2 M | 67.4 M | |
| Net Loss | -24.3 M | -25.6 M |
BioLineRx Quarterly Net Working Capital |
|
BioLineRx Stock Technical Analysis
BioLineRx technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
BioLineRx Period Price Range
Low | December 27, 2024
| High |
0.00 | 0.00 |
BioLineRx cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
BioLineRx December 27, 2024 Market Strength
Market strength indicators help investors to evaluate how BioLineRx stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioLineRx shares will generate the highest return on investment. By undertsting and applying BioLineRx stock market strength indicators, traders can identify BioLineRx entry and exit signals to maximize returns
BioLineRx Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for BioLineRx's price direction in advance. Along with the technical and fundamental analysis of BioLineRx Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BioLineRx to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.14) | |||
| Jensen Alpha | (1.34) | |||
| Total Risk Alpha | (1.73) | |||
| Treynor Ratio | 14.03 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for BioLineRx Stock Analysis
When running BioLineRx's price analysis, check to measure BioLineRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLineRx is operating at the current time. Most of BioLineRx's value examination focuses on studying past and present price action to predict the probability of BioLineRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLineRx's price. Additionally, you may evaluate how the addition of BioLineRx to your portfolios can decrease your overall portfolio volatility.